Are dietary caseins related to the onset and evolution of type 1 diabetes and celiac disease?

Casein: Production, Uses and Health Effects

Volumn , Issue , 2012, Pages 195-207

  Calderon de la Barca A M ^a   Mejia Leon M E ^a  

^a CENTRO DE INVESTIGACIÓN EN ALIMENTACIÓN Y DESARROLLO   (Mexico)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84892136722     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (47)

1. Aakerblom, H. K. (2011). The trial to reduce IDDM in the genetically al risk (TRIGR) study: Recruitment, intervention and follow-up. Diabetologia, 54, 627-633.
2. Araya, M., Mondragón, A., Pérez-Bravo, F., Roessler, J., Alarcón, T., Ríos, G. & Bergenfreid, C. (2000). Celiac disease in a Chilean population carrying Amerindian traits. Journal of Pediatric Gastroenterology & Nutrition, 31, 381-386.
3. Briani, C., Samaroo, D. & Alaedini, A. (2008). Celiac disease: From gluten to autoimmunity. Autoimmunity Reviews, 7, 644-650.
4. Bratanic, N., Smigoc, D., Mendez, A., Bratina, N., Battelino, T. & Vidan-Jeras, B. (2010). An influence of HLA-A, B, DR, DQ, and MICA on the occurrence of celiac disease in patients with type 1 diabetes. Tissue Antigens, 76, 208-215.
5. Bell, S. J., Grochoski, G. T. & Clarke, A. J. (2006). Health implications of milk containing [beta]-casein with the A2 Genetic variant. Critical Reviews in Food Science and Nutrition, 46, 93-100.
6. Berti, C., Trovato, C., Bardella, M. T. & Forlani F. (2003). IgA anti-gliadin antibody immunoreactivity to food proteins. Food and Agricultural Immunology, 15, 217-23.
7. Cabrera-Chávez, F., Rouzaud-Sández, O., Sotelo-Cruz, N. & Calderón de la Barca A. M. (2009). Bovine milk caseins and transglutaminase-treated cereal prolamins are differentially recognized by IgA of celiac disease patients according to their age. Journal of Agriculture and Food Chemistry, 57, 3754-3759.
8. Cabrera-Chávez, F. & de la Barca, A. M. (2009). Bovine milk intolerance in celiac disease is related to IgA reactivity to α and β-caseins. Nutrition, 25, 715-716.
9. Calder, P. C., Krauss-Etschmann, S., de Jong, E. C. (2006). Early nutrition and immunity-progress and perspectives. British Journal of Nutrition, 96, 774-790.
10. Calderón de la Barca A. M., Bolaños-Villar, A., Román-Pérez R. (1996). Protein contents of milk surrogates and their sanitary regulation. Salud Publica Mex, 38, 268-275.
11. Cocco, R. R., Järvinen, K. M., Han, N., Beyer, K. & Sampson, H. A. (2007). Mutational analysis of immunoglobulin E-binding epitopes of b-casein and b-lactoglobulin showed a heterogeneous pattern of critical amino acids between individual patients and pooled sera. Clinical and Experimental Allergy, 37, 831-838.
12. Couper, J. J., Steele, C., Beresford, S., Powell, T., McCaul, K., Pollard, A., Gellert, S., Tait, B., Harrison, L. & Colman, P. (1999). Lack of association between duration of breastfeeding or introduction of cow's milk and development of islet autoimmunity. Diabetes, 48, 2145-2149.
13. Darewicz, M., Dziuba, J. & Minkiewicz, P. (2007). Computational characterization and identification of peptides for in silico detection of potentially celiac-toxic proteins. Food Science and Technology International, 13, 125-33.
14. Dekking, L., Koning, F., Hosek, D., Ondrak, T. D., Taylor, S. L., Schroeder, J. W., Bauer, M. (2009). Intolerance of celiac disease patients to bovine milk is not due to the presence of T-cell stimulatory epitopes of gluten. Nutrition, 25, 122-3.
15. Deutsch, S. M., Molle, D., Gagnaire, V., Piot, M., Atlan, D., & Lortal S. (2000). Hydrolysis of sequenced β-casein peptides provides new insight into peptidase activity from thermophilic lactic acid bacteria and highlights intrinsic resistance of phosphopeptides. Applied and Environmental Microbiology, 66, 5360-5367.
16. Di Sabatino, A. & Corazza G. R. (2009). Coeliac Disease. The Lancet, 373, 180-1493.
17. Fasano, A. Surprises from celiac disease. (2009). Scientific American, 301, 54-61.
18. Fowler, M. J. (2010). Diabetes: Magnitude and mechanisms. Clinical Diabetes, 28, 42-46.
19. Green, P. & Jabri, B. (2003). Coeliac disease. The Lancet, 362, 383-391.
20. Greenberg, R., Groves, M. I. & Dower, H. J. (1984). Human beta-casein amino acid sequence and identification of phosphorylation sites. The Journal of Biological Chemistry, 259, 5132-5138.
21. Hermann, R., Knip, M., Veijola, R., Simell, O., Laine A. P., Akerblom, H. K., Groop, P. H., Forsblom, C., Pettersson-Fernholm, K. & Ilonen, J. (2003). Temporal changes in the frequencies of HLA genotypes in patients with Type 1 Diabetes-indication of an increased environmental pressure? Diabetologia, 46, 420-425.
22. Ivarsson, A., Hernell, O., Stenlund, H. & Persson, A. (2002). Breast-feeding protects against celiac disease. American Journal of Clinical Nutrition, 75, 914-921.
23. Kamiński S., Cieslińska, A. & Kostyra, E. (2007). Polymorphism of bovine beta-casein and its potential effect on human health. Journal of Applied Genetics, 48, 189-98.
24. Kantarova, D. & Buc, M. (2007). Genetic susceptibility to Type 1 Diabetes Mellitus in humans. Physiological Research, 56, 255-266.
25. Karvonen, M., Viik-Kajander, M., Moltchanova, E. & Libman, I. (2000). Incidence of childhood type 1 diabetes worldwide. Diabetes Care, 23, 516-1526.
26. Knip, M. (2003). Environmental triggers and determinants of beta cell autoimmunity and type 1 diabetes. Reviews in Endocrine & Metabolic Disorders, 4, 213-223.
27. Kristjánsson G., Venge, P. & Hällgreen, R. (2007). Mucosal reactivity to cow's milk protein in coeliac disease. Clinical and Experimental Immunology, 147, 449-455.
28. Laugesen, M. & Elliott, R. (2003). Ischaemic heart disease, Type 1 diabetes, and cow milk A1 beta-casein. The New Zealand Medical Journal, 116, U295.
29. Margaritte-Jeannin, P., Babron, M. C., Bourgey, M., Louka, A. S., Clot, F., Percopo, S., Coto, I., Hugot, J. P., Ascher, H., Sollid, L. M., Greco, L. & Clerget-Darpoux, F. (2004). HLADQ relative risks for coeliac disease in European populations: A study of the European genetics cluster on coeliac disease. Tissue Antigens, 63, 562-567.
30. Mychaleckyj, J. C., Noble, J., Moonsamy, P., Carlson, J., Varney, M., Post, J., Helmberg, W., Pierce, J., Bonella, P., Fear, A., Lavant, E., Louey, A., Boyle, S., Lane, J., Sali, P., Kim, S., Rappner, R., Williams, D., Perdue, L., Reboussin, D., Tait, B., Akolkar, B., Hilner, J. & Steffes, M., Erlich, H. (2010). HLA genotyping in the international Type 1 Diabetes genetics consortium. Clinical Trials, 7, S75-S87.
31. Nieminen, U., Kahri, A., Savilahti, E. & Farkkila, M. A. (2001). Duodenal disaccharidase activities in the follow-up of villous atrophy in coeliac disease. Scandinavian Journal of Gastroenterology, 36, 507-10.
32. Phadia A. B. Prevent Celiac Disease [online]. [2011-01-15] Available from: http://www.phadia.com/en-US/Laboratories/Autoimmunity/Partnerships/Prevent-Celiac-Disease/.
33. Phillips, S. M. (2010). A comparison of whey to caseinate. American Journal of Physiology-Endocrinology and Metabolism. 300, E610.
34. Reitelseder, S., Kjaer, M. & Holm, L. (2011). Reply to letter to the editor. American Journal of Physiology-Endocrinology and Metabolism, 300, E611-E612.
35. Rodrigo, L. (2009). Investigational therapies for celiac disease. Expert Opinion on Investigational Drugs, 18, 1865-1873.
36. Setty, M., Hormaza, L. & Guandalini, S. (2008). Celiac disease: Risk assessment, diagnosis and monitoring. Molecular Diagnosis & Therapy, 12, 289-298.
37. Shan, L., Molberg, O., Parrot, I., Hausch, F., Filiz, F., Gray, G., Sollid, L. & Khosla, C. (2002). Structural basis for gluten intolerance in celiac sprue. Science, 297, 2275-2279.
38. Sollid, L. M. & Lundin, K. E. A. (2009). Diagnosis and treatment of celiac disease. Mucosal Immunology, 2, 3-7.
39. Stepniak, D. & Koning, F. (2006). Celiac disease-sandwiched between innate and adaptive immunity. Human Immunology, 67, 460-468.
40. Thorn D. C., Ecroyd, H. & Carver, J. A. (2009). The two-faced nature of milk casein proteins: Amyloid fibril formation and chaperone-like activity. The Australian Journal of Dairy Technology, 64, 34-41.
41. Tollefsen, S., Arentz-Hansen, H., Fleckenstein, B., Molberg, O., Raki, M., Kwok, W., Jung, G., Lundin, K. & Sollid, L. (2006). HLA-DQ2 and DQ8 signatures of gluten cell epitopes in celiac disease. Journal of Clinical Investigation, 116, 226-2236.
42. Visser, J., Rozing, J., Sapone, A., Lammers, K. & Fasano, A. (2009). Tight junctions, intestinal permeability and autoimmunity: Celiac disease and type 1 diabetes paradigms. Annals of New York Academy of Science, 1165, 195-205.
43. Volta, U. & Villanacci, V. (2011). Celiac disease: diagnostic criteria in progress. Cellular and Molecular Immunology, 8, 96-102.
44. Westerholm-Ormio, M., Vaarala, O., Pihkala, P., Ilonen, J. & Savilahti, E. (2003). Immunologic activity in the small intestinal mucosa of pediatric patients with type 1 diabetes. Diabetes, 52, 2287-2295.
45. Woodford, K. A1 beta-casein, type 1Diabetes and links to other modern illnesses. International Diabetes Federation Western Pacific Congress [online]. (2008) [2011-01-15] Available from: http://www.guernsey.net/~wgcf/PageMill_Resources/A1_Betacasein%20Woodford.pdf.
46. Yeung, W. C., Rawlinson, W. D., & Craig, M. E. (2011). Enterovirus infection and type 1 diabetes mellitus: Systematic review and meta-analysis of observational molecular studies. British Medical Journal, 342, d35.
47. Yin, H. & Miao J. Y. (2010). Protective effect of beta-casomorphin-7 on type 1 diabetes rats induced with streptozotocin. Peptides, 31, 1725.